As part of Icon Group, Australia’s largest dedicated provider of cancer care with an in-depth clinical trials program, Icon in Singapore is committed to providing access to research and clinical trials to patients across ASEAN.
Being able to deliver research and clinical trials opportunities is an important part of delivering the best cancer care possible. At Icon, we continue to invest in clinical trials and have played an integral role in the development of new and emerging treatments options across haematology, medical oncology and radiation oncology.
Through leveraging our international depth of experience and network of clinicians, we can continue to support our patients through their treatment and offer them opportunities across a range of national and international clinical trials. We want to ensure that you and your loved ones are well informed and have access to new emerging treatments and up-to-date research.
Clinical trials provide hope, access and opportunity for cancer patients and help us improve cancer care for people now and into the future by contributing to breakthroughs and advancements to the ways we can treat cancers.